The Munich, Germany–based surgical robotic startup Medineering has announced the successful closing of its Series A round. The investment of Medineering’s new strategic partner Brainlab will enable the startup continuing its way to becoming a global surgical robotic manufacturer. Specifically, the investment will be used for the commercialization of the first robot for endo- and transnasal surgery. The financial details of the deal were not immediately disclosed.
“We started the development of our modular platform in October 2014 consisting of an intelligent arm and application specific robotic hands, which can be exchanged depending on the surgical needs. We got a great feedback for the first prototypes of our robotic hand for endo- and transnasal surgery. This motivated us to open our platform also for third-party robotic hands and instruments, depending on the dedicated surgical tasks,” said Stephan Nowatschin, CEO and co-founder of Medineering. “The success story of Brainlab has motivated and inspired us from the early stage of Medineering.”
“We were impressed by the potential of the technology, the ambitious founders and the team of Medineering,” said Rainer Birkenbach, executive vice president at Brainlab. “The promising approach of Medineering addresses reasonably the surgical needs of robotic assistance in the OR.”
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]